| Financial Year |
March 31 2023 |
| Monetary Funds |
377,446,897.84 |
| Held-for-trading Financial Assets |
580,386,475.10 |
| Notes Receivable |
37,456,743.12 |
| Accounts Receivable |
793,968,222.55 |
| Advances to Suppliers |
14,092,794.46 |
| Other Receivables |
47,664,831.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
440,429,875.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
494,623,184.33 |
| Total Current Assets |
3,010,236,142.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
34,105,829.64 |
| Investment Properties |
-- |
| Fixed Assetes |
1,905,370,625.87 |
| Under-construction Projects |
142,765,353.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,054,808.81 |
| R&D expenses |
-- |
| Goodwill |
264,051,117.20 |
| Long-Term Deferred and Prepaid Expenses |
28,358,529.86 |
| Deferred Income Tax Assets |
69,529,339.82 |
| Other Non-Current Assets |
60,705,269.88 |
| Sub-Total of Non-Current Assets |
2,651,081,474.91 |
| Total Assets |
5,661,317,617.76 |
| Short-Term Loans |
13,795,855.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
354,435,386.04 |
| Accounts Payable |
591,522,344.93 |
| Accounts Received In Advance |
5,388,758.69 |
| Employee Compensation Payable |
68,441,843.47 |
| Taxes Payable |
58,851,582.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
55,246,222.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,522,585.64 |
| Other Current Liabilities |
29,618,936.84 |
| Sub-Total of Current Liabilities |
1,236,749,654.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,752,172.79 |
| Deferred Income Tax Liabilities |
965,477.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
237,667,960.75 |
| Total Liabilities |
1,474,417,614.79 |
| Paid-In Capital(Or Share Stock) |
864,192,474.00 |
| Capital Surplus |
2,585,779,037.38 |
| Surplus Reserve |
66,902,659.51 |
| LESS:Treasury Stock |
29,389,464.00 |
| Undistributed Profits |
586,569,057.42 |
| Minority Stockholder's Interest |
112,686,700.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,074,213,302.45 |
| Owner's Equity（Stockholder's Equity） |
4,186,900,002.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,661,317,617.76 |
